Published in Ter Arkh on January 01, 2005
A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol (2007) 1.86
Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients. Saudi J Gastroenterol (2014) 0.75
Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol (1998) 0.96
Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol Lett (2002) 0.85
Sequence specificity of isolated DNA-adenine methylases from Mycobacterium smegmatis (butyricum) and Shigella sonnei 47 cells. Biochem Int (1985) 0.83
Substrate specificity of catalytic autoantibodies in neurodegenerative processes. Dokl Biochem Biophys (2007) 0.80
Sequence specificity of isolated DNA-cytosine methylases from Shigella sonnei 47 cells. Biochem Int (1984) 0.80
[Site-specificity of DNA methylases from Shigella sonnei 47 cells]. Biokhimiia (1985) 0.80
[Connection of multiple sclerosis in the Russian population with alleles of the major histocompatibility complex DRB1 gene]. Mol Biol (Mosk) (1998) 0.78
[Correction of hypercoagulation in head traumas in patients with purulent sinusitis]. Vestn Otorinolaringol (2003) 0.78
[Catalytic autoantibodies--a new molecular instrument in cardiology and ophthalmology]. Ter Arkh (2006) 0.78
[Frequency of genes speA, speB, and speC in Streptococcus pyogenes strains and the identification of the infective agent by polymerase chain reaction]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.77
[Endoscopic removal of isolated gastrinoma of the duodenum after Billroth II gastric resection]. Khirurgiia (Mosk) (1993) 0.76
[The current concept of immunological disorders in the case of basal-cell carcinoma]. Arkh Patol (2009) 0.76
[Plasma fibronectin in gastric and duodenal ulcer]. Klin Med (Mosk) (1999) 0.76
β1 integrin as the integrating component in cell-cell cooperation for maintenance of lens transparency. Dokl Biochem Biophys (2014) 0.76
[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis]. Vestn Ross Akad Med Nauk (2010) 0.76
[Aproaches to immunotherapy in different immunophenotypes of cutaneous basal cell carcinoma]. Vopr Onkol (2012) 0.76
[Cytokines and their role in pathogenesis of diabetic retinopathy]. Vestn Oftalmol (2011) 0.76
[DNA-abzymes in rheumatoid arthritis: pathogenetic and clinical significance]. Ter Arkh (2005) 0.76
Natural antibody catalytic activities in mice with autoimmune disorders. Dokl Biochem (2001) 0.76
[Disturbance of immunogenesis in patients with systemic lupus erythematosus]. Ter Arkh (1989) 0.75
[The cyclic nucleotide system of patients with focal scleroderma]. Vestn Dermatol Venerol (1990) 0.75
[Regulatory role of the immune system in the organism]. Ross Fiziol Zh Im I M Sechenova (2010) 0.75
[Dynamics of disorders of cellular and humoral immunity parameters in patients with insulin-dependent diabetes mellitus]. Probl Endokrinol (Mosk) (1992) 0.75
[Isoelectric focusing of DNA-methylases from Shigella sonnei 47]. Vopr Med Khim (1983) 0.75
Caspase-dependent cytotoxicity of anti-DNA autoantibodies. Dokl Biochem Biophys (2001) 0.75
[Creatine phosphokinase in the cerebrospinal fluid of patients with stroke in the acute period]. Zh Nevropatol Psikhiatr Im S S Korsakova (1989) 0.75
[A comparative analysis of the proliferative response of blood mononuclears to mitogens]. Lab Delo (1990) 0.75
[The HLA system antigens in patients with cardiovascular diseases]. Ter Arkh (1990) 0.75
[Pancreatic neoplasms in patients with chronic pancreatitis and pancreofibrosis (clinico-anatomical observations)]. Ter Arkh (1972) 0.75
[Use of an immunotoxin against the human T-lymphocyte CD5 antigen for removing "passenger" lymphocytes from kidney transplants]. Dokl Akad Nauk (1995) 0.75
[Use of pikamilon in the combined treatment of patients with cerebral circulatory disorders]. Vrach Delo (1988) 0.75
[Case of pancreatitis complicated by brain abscess and psychosis]. Klin Med (Mosk) (1973) 0.75
Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects. Bull Exp Biol Med (2005) 0.75
[The use of achievements in human molecular immunogenetics in the management of type 1 diabetes mellitus]. Vestn Ross Akad Med Nauk (2008) 0.75
[Case of renal osteodystrophy in a young patient]. Klin Med (Mosk) (1974) 0.75
[Syndrome of secondary immunodeficiency: pathogenesis and approaches to treatment]. Klin Med (Mosk) (2002) 0.75
Human leukocyte antigens as markers of predisposition to ischaemic heart disease in Russian and Georgian populations. Biomed Sci (1990) 0.75
[Glial tumors of the brain: current aspects of their classification and bases for genetic predisposition]. Arkh Patol (2009) 0.75
[Modern programs of treatment and rehabilitation of patients with basaliomas: their pathogenic substantiation and clinical effectiveness]. Vestn Ross Akad Med Nauk (2005) 0.75
[Immunogenodiagnosis and postinfection immunodeficiency syndrome in a hospital doctor's practice (a review of literature)]. Klin Lab Diagn (2006) 0.75
[Immunogenetic achievements for medicine]. Vestn Ross Akad Med Nauk (1999) 0.75
[Clinico-immunological parallels in patients with focal scleroderma]. Vestn Dermatol Venerol (1989) 0.75
[Immunogenetics of type 1 diabetes mellitus--from fundamental ideas to medical practice]. Vestn Ross Akad Med Nauk (2012) 0.75
[Evaluation of thymectomy in the treatment of partial red blood cell aplasia in the bone marrow]. Klin Med (Mosk) (1978) 0.75
[EHF-therapy of herpetic keratouveitis]. Vopr Kurortol Fizioter Lech Fiz Kult (2002) 0.75
[siRNA-mediated inhibition of respiratory syncytial virus replication]. Vopr Virusol (2007) 0.75
[Antibody-mediated proteolysis of myelin-associated proteins as a new mechanism of control over demyelinization processes in multiple sclerosis]. Vestn Ross Akad Med Nauk (2007) 0.75
[Selective elimination of human T-leukemia cells with the use of a conjugate of the A-chain of ricin and a monoclonal antibody against CD5-antigen of T-lymphocytes]. Dokl Akad Nauk SSSR (1989) 0.75
[Genetic markers in insulin-dependent diabetes (history of the problem, current status, perspectives)]. Klin Med (Mosk) (1993) 0.75
[Fractionation and purification of DNA-methylases from Shigella sonnei 47]. Biokhimiia (1985) 0.75
[HLA-associated predisposition to dilated cardiomyopathy]. Klin Med (Mosk) (1990) 0.75
[Catalytic autoantibodies and their future in practical medicine]. Ter Arkh (2002) 0.75
Isoelectric focusing of bacterial DNA methylases. Biochem Int (1983) 0.75
[Postinfection autoimmune syndrome: pathogenetic features and modern protocols of clinical immunogenodiagnosis]. Ter Arkh (2007) 0.75
[Dynamics of lipid peroxidation during adaptation of man to new ecological environment]. Biull Eksp Biol Med (1997) 0.75
[Immunologic indices in a varying course of lepromatous leprosy]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[The immunophysiological and immunopathological aspects of scleroderma systematica: fundamental and clinical aspects]. Patol Fiziol Eksp Ter (2007) 0.75
[Introduction to medical abzymology: the present and the prospect]. Vestn Ross Akad Med Nauk (2005) 0.75
[Study of the conditions of activation and stabilization of DNA-methylases from Shigella sonnei 47 during fractionation, purification and storage]. Biokhimiia (1986) 0.75
[Tissue-specific retinal proteins in vertebrate evolution]. Zh Evol Biokhim Fiziol (1981) 0.75
[Possible role of natural cytotoxicity in impairment of collagen catabolism in focal scleroderma]. Vopr Med Khim (1988) 0.75
[Autoimmune myocarditis: current aspects of immune pathogenesis]. Vestn Ross Akad Med Nauk (2002) 0.75
[Achievements and prospects of clinical abzymology]. Vestn Ross Akad Med Nauk (2005) 0.75
[Glial tumors of the brain: classification, present-day aspects of immunopathogenesis and immunogenetic diagnostics]. Vestn Ross Akad Med Nauk (2005) 0.75
[Immune response genes products in human physiology]. Ross Fiziol Zh Im I M Sechenova (2012) 0.75
[The connection between the decomposition of mature collagen and the level of natural cytotoxicity in patients with focal scleroderma]. Vopr Med Khim (1991) 0.75
[Immunocorrecting therapy in focal scleroderma]. Vestn Dermatol Venerol (1987) 0.75
[Thermography in the differential diagnosis of breast neoplasms]. Khirurgiia (Mosk) (1974) 0.75
[Physiology of immune response genes]. Ross Fiziol Zh Im I M Sechenova (2003) 0.75
[Amyloidosis in psoriatic polyarthritis]. Klin Med (Mosk) (1974) 0.75
[Modern approaches to treating and preventing autoimmune myocarditis]. Vestn Ross Akad Med Nauk (2003) 0.75
[Current pathogenetic model of rheumatoid arthritis and its role in clinical practice]. Ter Arkh (2004) 0.75
[Genetic predisposition factors for multiple sclerosis (based on the data from genotyping patients of the Russian ethnic group)]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.75
[Antibodies as a molecular-diagnostic tool in serodiagnostics and seroprognostication of autoimmune myocarditis (literature review)]. Klin Lab Diagn (2005) 0.75
[HLA antigens in hypertension patients with myocardial hypertrophy of the left ventricle]. Ter Arkh (1989) 0.75
[Cancer and reticulosarcoma of the stomach]. Arkh Patol (1973) 0.75
[Primary myocardiopathies in the aged]. Klin Med (Mosk) (1972) 0.75
[New ideas of the physiological role of the genes' HLA in reproductive process]. Ross Fiziol Zh Im I M Sechenova (2006) 0.75
[A clinico-immunological assessment of the efficacy of combined methods of treating patients with different immunopathological forms of focal scleroderma]. Vestn Dermatol Venerol (1990) 0.75
[Case of cancer with double localization]. Klin Med (Mosk) (1972) 0.75
[DNA-abzymes and their clinical significance in systemic lupus erythematosis]. Ter Arkh (2001) 0.75
[Molecular genetic approaches to studying HLA systems: new prospects in basic and applied research]. Biull Eksp Biol Med (1994) 0.75
[Cytokines as a diagnostic and therapeutic tool in patients with myocarditis]. Vestn Ross Akad Med Nauk (2005) 0.75
[Catalytic autoantibodies as a new molecular instrument in rheumatological practice]. Ter Arkh (2006) 0.75
[Thermography with glycemia test used in the diagnosis of breast diseases]. Khirurgiia (Mosk) (1978) 0.75
[The use of fermented milk drink with topinambur for the treatment of Helicobacter infection in the liquidators of Chernobyl nuclear power plant accident]. Vopr Pitan (2003) 0.75
On the catalytic activity of autoantibodies in multiple sclerosis. Dokl Biochem Biophys (2004) 0.75
[HLA-associated susceptibility to ischemic heart disease]. Klin Med (Mosk) (1990) 0.75
[Dynamics of parameters of the functional activity of the thyroid gland and adrenal cortex during human adaptation to new ecologic conditions]. Fiziol Cheloveka (1997) 0.75
[The physiological role of the HLA system and the population aspects]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[Immunological aspects of laboratory diagnosis of chronic urticaria]. Klin Lab Diagn (2001) 0.75
[Immunochemistry in ophthalmo-oncology: problems and prospects]. Vestn Oftalmol (1983) 0.75
[Antithyroid antibodies of varying specificity in the pathogenesis and diagnosis of autoimmune thyroid diseases]. Ter Arkh (2009) 0.75
[Chronic pyelonephritis: immunopathogenesis and clinicodiagnostic value of its specific features]. Ter Arkh (2007) 0.75
["Functionality" of antibodies: clinical implications]. Ter Arkh (2008) 0.75
[Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis]. Arkh Patol (2007) 0.75
[Autoantibodies of various levels of specificity and function in pathogenesis and diagnosis of autoimmune thyroid diseases]. Ter Arkh (2008) 0.75
Factors of activation and stabilization of DNA-methylases from Shigella sonnei 47 and Mycobacterium smegmatis butyricum cells. Biochem Int (1987) 0.75
[Architectonics of cell subpopulations of peripheral blood in patients with autoimmune myocarditis: clinical and pathogenetic aspects]. Ter Arkh (2008) 0.75